Albireo Pharma (ALBO) PT Lowered to $50 at H.C. Wainwright
Get Alerts ALBO Hot Sheet
Price: $44.15 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 26
Join SI Premium – FREE
H.C. Wainwright analyst Ed Arce lowered the price target on Albireo Pharma (NASDAQ: ALBO) to $50.00 (from $64.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- WaterBridge Infrastructure (WBI) PT Raised to $40 at Raymond James
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share